Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism MST1 inhibitors(macrophage stimulating 1 inhibitors), MST2 inhibitors(serine/threonine kinase 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H20ClN5O |
InChIKeyAYRVYPOFYQSRNH-UHFFFAOYSA-N |
CAS Registry2869148-13-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | US | 27 Jan 2022 |